Literature DB >> 25758542

Stimulation of the Angiotensin II AT2 Receptor is Anti-inflammatory in Human Lipopolysaccharide-Activated Monocytic Cells.

Mario Menk1, Jan Adriaan Graw, Clarissa von Haefen, Marco Sifringer, David Schwaiberger, Thomas Unger, Ulrike Steckelings, Claudia D Spies.   

Abstract

Recently, AT2 receptors have been discovered on the surface of human immunocompetent cells such as monocytes. Data on regulative properties of this receptor on the cellular immune response are poor. We hypothesized that direct stimulation of the AT2 receptor mediates anti-inflammatory responses in these cells. Human monocytic THP-1 and U937 cells were stimulated with lipopolysaccharide (LPS) and the selective AT2 receptor agonist Compound 21 (C21). Expression of pro- and anti-inflammatory cytokines IL-6, IL-10, tumor necrosis factor-α (TNFα), and IL-1β were analyzed on both the transcriptional and the translational level over course of time. Treatment with C21 attenuated the expression of TNFα, IL-6, and IL-10 after LPS challenge in both cell lines in a time- and dose-dependent manner. We conclude that selective AT2 receptor stimulation acts anti-inflammatory in human monocytes. Modulation of cytokine response by AT2 receptor activation might be a beneficial and novel treatment concept in inflammatory conditions.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25758542     DOI: 10.1007/s10753-015-0146-9

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  41 in total

1.  Angiotensin II Type-2 receptors modulate inflammation through signal transducer and activator of transcription proteins 3 phosphorylation and TNFα production.

Authors:  Peter M Abadir; Jeremy D Walston; Robert M Carey; Helmy M Siragy
Journal:  J Interferon Cytokine Res       Date:  2011-02-02       Impact factor: 2.607

2.  Macrophage polarization by angiotensin II-type 1 receptor aggravates renal injury-acceleration of atherosclerosis.

Authors:  Suguru Yamamoto; Patricia G Yancey; Yiqin Zuo; Li-Jun Ma; Ryohei Kaseda; Agnes B Fogo; Iekuni Ichikawa; MacRae F Linton; Sergio Fazio; Valentina Kon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-10-06       Impact factor: 8.311

Review 3.  The regulation of IL-10 production by immune cells.

Authors:  Margarida Saraiva; Anne O'Garra
Journal:  Nat Rev Immunol       Date:  2010-02-15       Impact factor: 53.106

4.  Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist.

Authors:  Yiqian Wan; Charlotta Wallinder; Bianca Plouffe; Hélène Beaudry; A K Mahalingam; Xiongyu Wu; Berndt Johansson; Mathias Holm; Milad Botoros; Anders Karlén; Anders Pettersson; Fred Nyberg; Lars Fändriks; Nicole Gallo-Payet; Anders Hallberg; Mathias Alterman
Journal:  J Med Chem       Date:  2004-11-18       Impact factor: 7.446

5.  Ethanol-induced downregulation of the angiotensin AT2 receptor in murine fibroblasts is mediated by PARP-1.

Authors:  Mario Menk; Clarissa von Haefen; Heiko Funke-Kaiser; Marco Sifringer; Jan H Schefe; Sebastian Kirsch; Kerstin Seidel; Jana Reinemund; Ulrike M Steckelings; Thomas Unger; Claudia D Spies
Journal:  Alcohol       Date:  2010-06-18       Impact factor: 2.405

6.  Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase.

Authors:  A L Albiston; S G McDowall; D Matsacos; P Sim; E Clune; T Mustafa; J Lee; F A Mendelsohn; R J Simpson; L M Connolly; S Y Chai
Journal:  J Biol Chem       Date:  2001-11-13       Impact factor: 5.157

Review 7.  Angiotensin II as a pro-inflammatory mediator.

Authors:  M Ian Phillips; Shuntaro Kagiyama
Journal:  Curr Opin Investig Drugs       Date:  2002-04

8.  Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis.

Authors:  Satoshi Kurisu; Ryoji Ozono; Tetsuya Oshima; Masayuki Kambe; Takafumi Ishida; Hiroshi Sugino; Hideo Matsuura; Kazuaki Chayama; Yasuhiro Teranishi; Osamu Iba; Katsuya Amano; Hiroaki Matsubara
Journal:  Hypertension       Date:  2003-01       Impact factor: 10.190

9.  Angiotensin AT2 receptor stimulation is anti-inflammatory in lipopolysaccharide-activated THP-1 macrophages via increased interleukin-10 production.

Authors:  Isha Dhande; Wanshu Ma; Tahir Hussain
Journal:  Hypertens Res       Date:  2014-09-11       Impact factor: 3.872

10.  AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expression.

Authors:  Pawel Namsolleck; Francesco Boato; Katja Schwengel; Ludovit Paulis; Katherine S Matho; Nathalie Geurts; Christa Thöne-Reineke; Kristin Lucht; Kerstin Seidel; Anders Hallberg; Björn Dahlöf; Thomas Unger; Sven Hendrix; U Muscha Steckelings
Journal:  Neurobiol Dis       Date:  2012-11-19       Impact factor: 5.996

View more
  13 in total

Review 1.  Emerging Role of Angiotensin AT2 Receptor in Anti-Inflammation: An Update.

Authors:  Sanket N Patel; Naureen Fatima; Riyasat Ali; Tahir Hussain
Journal:  Curr Pharm Des       Date:  2020       Impact factor: 3.116

Review 2.  Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease.

Authors:  Carlos M Ferrario; Adam E Mullick
Journal:  Pharmacol Res       Date:  2017-05-29       Impact factor: 7.658

Review 3.  Angiotensin II Type 2 Receptor: A Target for Protection Against Hypertension, Metabolic Dysfunction, and Organ Remodeling.

Authors:  Naureen Fatima; Sanket N Patel; Tahir Hussain
Journal:  Hypertension       Date:  2021-04-12       Impact factor: 10.190

4.  The effect of high glucose on the inhibitory action of C21, a selective AT2R agonist, of LPS-stimulated tissue factor expression in human mononuclear cells.

Authors:  Cristina Balia; Valentina Scalise; Silvana Cianchetti; Francesca Faita; Tommaso Neri; Vittoria Carnicelli; Riccardo Zucchi; Alessandro Celi; Roberto Pedrinelli
Journal:  J Inflamm (Lond)       Date:  2016-05-04       Impact factor: 4.981

5.  Central Infusion of Angiotensin II Type 2 Receptor Agonist Compound 21 Attenuates DOCA/NaCl-Induced Hypertension in Female Rats.

Authors:  Shu-Yan Dai; Yu-Ping Zhang; Wei Peng; Ying Shen; Jing-Jing He
Journal:  Oxid Med Cell Longev       Date:  2015-12-13       Impact factor: 6.543

6.  Leucine-Rich Repeat Kinase 2 Influences Fate Decision of Human Monocytes Differentiated from Induced Pluripotent Stem Cells.

Authors:  Anna Speidel; Sandra Felk; Peter Reinhardt; Jared Sterneckert; Frank Gillardon
Journal:  PLoS One       Date:  2016-11-03       Impact factor: 3.240

7.  Azilsartan improves the effects of etanercept in patients with active rheumatoid arthritis: a pilot study.

Authors:  Naza Mohammed Ali Mahmood; Saad Abdulrahman Hussain; Raouf Rahim Mirza
Journal:  Ther Clin Risk Manag       Date:  2018-08-07       Impact factor: 2.423

Review 8.  Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders.

Authors:  Ludovit Paulis; Sébastien Foulquier; Pawel Namsolleck; Chiara Recarti; Ulrike Muscha Steckelings; Thomas Unger
Journal:  Drugs       Date:  2016-01       Impact factor: 9.546

9.  Lipopolysaccharide-Induced Nitric Oxide, Prostaglandin E2, and Cytokine Production of Mouse and Human Macrophages Are Suppressed by Pheophytin-b.

Authors:  Chun-Yu Lin; Wen-Hung Wang; Shin-Huei Chen; Yu-Wei Chang; Ling-Chien Hung; Chung-Yi Chen; Yen-Hsu Chen
Journal:  Int J Mol Sci       Date:  2017-12-06       Impact factor: 5.923

10.  Angiotensin II type 2 receptor agonist Compound 21 attenuates pulmonary inflammation in a model of acute lung injury.

Authors:  Mario Menk; Jan Adriaan Graw; Clarissa von Haefen; Hendrik Steinkraus; Burkhard Lachmann; Claudia D Spies; David Schwaiberger
Journal:  J Inflamm Res       Date:  2018-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.